Global Cellular Health Screening Market was valued at $2.6 billion in 2022 and is set to witness a CAGR of 9% by 2027 - Growing Applications in Personalized Medicine

Cellular health screening or testing is one of the most determining factors of health based on major life factors such as lifestyle, environment, emotions and diet. It can be used to analyze all the inflammatory diseases such as allergies, asthma, arthritis, autoimmune diseases or inflammatory gastrointestinal issues. This test also helps in monitoring a patient’s progress throughout his/her medical treatment and offers detailed reports to analyze and assess further improvements on a cellular level. Cellular health screening also helps in determining the cellular health & function, fat mass, intra & extracellular fluid levels, cellular toxicity, and muscle mass, etc.

Technological Developments & Innovations in Cellular Health Screening Market to Trigger Its Global Market Demand

Consistent and quick developments and innovations in the cellular health screening tests have enabled to develop an efficient and easy-to-use tests with advanced capabilities such as automatic detection of telomers, fast turnaround time and improved accuracy. Such innovations tend to offer a competitive edge to all manufacturers and hence, all leading market players are focusing on new product development to further strengthen their position in the cellular health screening market. 

Some of the technological developments and innovations are listed below:-

• In December 2022, Regenerus labs launched its TruAge Complete, an advanced epigenetic test which offers an accurate, comprehensive and actionable analysis of a patient’s biological ageing and health insights.
• In August 2022, Proteomics International Laboratories announced the spin-off of an independent business for the commercialization of its patented ‘2-tag’ technology developed together with University of Western Australia.

Growing Research Activities to Fuel the Upcoming Advancements in Cellular Health Screening Market

Rapid growth in the global cellular health screening market is poised to be driven by the growing number of public awareness campaigns aimed at educating people on the major symptoms of chronic diseases and how to prevent them in order to reduce the epidemics. Due to the growing patient awareness and high demand, there is a urgent need for novel cellular health screening kits and services which has forced researchers to emphasis on technological advancements and develop advanced diagnostic tests.

Some of the recent developments and advancements are listed below-

• In February 2023, Duke-NUS Medical School announced that Scientists at the Duke-NUS Medical School, National Heart Centre Singapore (NHCS) and colleagues in Singapore, China and the US have developed a test to rapidly and precisely measure the length of a single telomere. The new approach is expected to be used as a predictive biomarker for human ageing and disease at the individual level.
• In March 2021, Researchers at Queen Mary University of London and Cardiff University developed a rapid laboratory test for diagnosing patients showing symptoms arising from telomeropathies. This high-throughput single telomere length analysis (HT-STELA) technique is a DNA-based blood test and can be applied to a broader range of samples including fresh or frozen blood samples.

Competitive Landscape Analysis: Cellular Health Screening Market

The global cellular health screening market is marked by the presence of some of the leading and well-established market players which are listed below: -

• Quest Diagnostics (US)
• Telomere Diagnostics (US)
• SpectraCell Laboratories (US)
• Genova Diagnostics (US)
• LabCorp Holdings (US)
• Repeat Diagnostics, Inc. (Canada)
• Life Length (Spain)

The global cellular health screening market is an emerging market and is estimated to gain a consistent momentum in the upcoming years due to a strong focus on technological innovations, broader acceptance and growing awareness on preventive healthcare, an increasing aging population and primary focus of leading market players to expand their geographic reach to strengthen their market position.